Australian stingless bees, known as sugarbag bees, are at the forefront of a promising new study aiming to tackle the growing threat of antibiotic resistance. Researchers have uncovered that the honey and propolis from these bees may provide a potent solution against stubborn bacterial infections that often resist conventional treatments.

The Research Initiative

A team from the University of Sydney delved into the potential medicinal properties of honey and propolis produced by these native bees. Their investigation highlighted the honey’s remarkable ability to halt the growth of 16 different bacterial and fungal pathogens, even those notorious for their resistance to treatment.

Unlike the extensively studied European honey bee, Australia’s stingless bees have not been the primary focus of scientific inquiry, despite their honey’s traditional use in Indigenous medicine. This research, led by PhD candidate Jasmin Li, sought to bridge the knowledge gap regarding these native bees’ contributions to health science.

Impressive Findings

Among the tested pathogens, the honey showed effectiveness against two particularly challenging hospital pathogens: Pseudomonas aeruginosa and Klebsiella pneumoniae. These microbes often defy treatment, posing significant challenges in medical settings. The findings reveal that the sugarbag honey’s antimicrobial properties parallel those of renowned medical-grade honeys like Manuka and Jarrah, offering a comparable benchmark for future studies.

Moreover, the research demonstrates that the honey’s efficacy extends to combating common fungal infections such as ringworm and athlete’s foot, widening the scope of its potential medicinal applications.

The Battle Against Antimicrobial Resistance

The study arrives at a crucial time when the world faces an escalating crisis of drug-resistant infections. Pathogens evolving to withstand existing medications create an urgent need for alternative treatments. Australian stingless bee honey presents a hopeful possibility, providing a natural substance that can impede resistant bacterial strains.

The research also underscores the unique properties of stingless bee propolis. Unlike the broad-spectrum activity observed in other bee species, this propolis is particularly selective, offering potent effects on certain pathogens while sparing others. This selectivity could mean more precise therapeutic applications, targeting harmful bacteria without disturbing beneficial microbes.

Next Steps in Exploration

While the findings are promising, researchers admit that the journey to understanding these bees’ potential is far from complete. Dr. Kenya Fernandes, a supervisor on the project, acknowledges that further exploration is needed to identify the compounds giving this honey its powerful properties. Such discoveries could lead to new, effective treatments for difficult infections, representing a significant step in the fight against antibiotic resistance.

Photo by National Cancer Institute on Unsplash